Gidday J M, Maceren R G, Shah A R, Meier J A, Zhu Y
Department of Neurology and Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2624-33.
The authors and others have shown previously that the purine nucleoside adenosine is a potent vasodilator in the retinal microcirculation, mediating increases in retinal blood flow (RBF) in response to several autoregulatory stimuli. The current experiments were undertaken to elucidate the involvement of adenosine triphosphate (ATP)-sensitive potassium (KATP) channels and the adenylate cyclase--cyclic adenosine monophosphate (cAMP) second-messenger system in the transduction of adenosine's hyperemic response.
Retinal fluorescein angiograms were videorecorded in isoflurane-anesthetized newborn pigs, and changes in arteriovenous transit times and retinal arteriolar and venular diameters were used to estimate stimulus-induced changes in RBF.
Intravitreal perivascular microsuffusion of 5 nmol and 50 nmol adenosine caused dose-dependent increases in RBF of 79% +/- 4% (P < 0.05; n = 5) and 323% +/- 61% (P < 0.05; n = 5), respectively. The KATP channel antagonist glibenclamide (0.5 nmol and 5 nmol) caused a significant, dose-dependent attenuation of the hyperemic response to 5 nmol adenosine. The specificity of glibenclamide for blocking KATP channels was demonstrated by its ability to block by 94% +/- 6% (P < 0.05; n = 5) the increase in RBF (94% +/- 7%; P < 0.05) elicited by the intravitreal microsuffusion of the KATP channel agonist cromakalim (5 nmol), whereas it had no effect on the 103% +/- 12% increase in RBF (P < 0.05; n = 5) induced by the nitric oxide donor sodium nitroprusside (15 nmol). Adenosine-induced hyperemia was not potentiated by forskolin (1.7 nmol; n = 4), an adenylate cyclase activator, and was not attenuated by dideoxyadenosine (5 nmol; n = 4), an adenylate cyclase inhibitor. In addition, no significant increases in RBF could be elicited by 2.5 to 25 nmol 8-bromo-cAMP (n = 4), a membrane-permeable cAMP analog.
These results in the piglet indicate that adenosine increases blood flow in the retina by activating KATP channels, not by increasing in cyclic AMP secondary to adenylate cyclase activation. They also underscore the potential importance of KATP channels in the transduction of retinal vasodilatative responses to other agonists.
作者及其他研究人员先前已表明,嘌呤核苷腺苷是视网膜微循环中一种有效的血管扩张剂,可介导视网膜血流量(RBF)在多种自身调节刺激下增加。当前实验旨在阐明三磷酸腺苷(ATP)敏感性钾(KATP)通道及腺苷酸环化酶 - 环磷酸腺苷(cAMP)第二信使系统在腺苷充血反应转导中的作用。
在异氟烷麻醉的新生猪中对视网膜荧光血管造影进行视频记录,利用动静脉通过时间以及视网膜小动脉和小静脉直径的变化来估计刺激引起的RBF变化。
玻璃体内血管周围微量灌注5 nmol和50 nmol腺苷分别导致RBF剂量依赖性增加79%±4%(P<0.05;n = 5)和323%±61%(P<0.05;n = 5)。KATP通道拮抗剂格列本脲(0.5 nmol和5 nmol)使对5 nmol腺苷的充血反应出现显著的剂量依赖性减弱。格列本脲阻断KATP通道的特异性通过其能阻断94%±6%(P<0.05;n = 5)由玻璃体内微量灌注KATP通道激动剂克罗卡林(5 nmol)引起的RBF增加(94%±7%;P<0.05)得以证明,而它对一氧化氮供体硝普钠(15 nmol)诱导的RBF增加103%±12%(P<0.05;n = 5)无影响。腺苷酸环化酶激活剂福斯可林(1.7 nmol;n = 4)未增强腺苷诱导的充血,腺苷酸环化酶抑制剂双脱氧腺苷(5 nmol;n = 4)也未减弱该反应。此外,2.5至25 nmol的8 - 溴 - cAMP(n = 4),一种可透过细胞膜的cAMP类似物,未引起RBF显著增加。
这些在仔猪中的结果表明,腺苷通过激活KATP通道而非通过增加腺苷酸环化酶激活后的环磷酸腺苷来增加视网膜血流量。它们还强调了KATP通道在视网膜对其他激动剂的血管舒张反应转导中的潜在重要性。